NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) Q1 2025 Management View CEO Dave Rosa highlighted the strong performance of the OneRF ablation system, which is the first FDA-cleared product ...
Zimmer Biomet provided 2025 guidance of constant currency ... supported by increased penetration of the Persona portfolio and ROSA Robotics. Hips grew 4%, bolstered by the initial rollout of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback